Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers achieved ahead of targetClinical execution and data ...
Q3 2025 Earnings Call November 11, 2025 10:00 AM ESTCompany ParticipantsPeter Hoetzinger - Vice Chairman, Co-CEO ...
Upon reviewing U.S. Bureau statistics, the organization found that Iowa is increasingly dependent on foreign migration for its demographic growth. Since 2021, Iowa’s population has grown by 1.34 ...